Eugenol's Molecular Warfare against Human Leukemia K562 cells: In Vitro Insights to Chemotherapeutic Potentials
Article Sidebar
Main Article Content
Abstract
Background: The search for effective anticancer agents has led to an increased focus on natural compounds, given their role as the foundation for many chemotherapeutic drugs. Eugenol (EUG) and Bis-Eugenol (Bis-EUG), derived from clove oil, have shown promise due to their antioxidative, anti-inflammatory, pro-apoptotic, and anti-proliferative properties across various cancer cell lines. This study aims to elucidate the chemotherapeutic potential of EUG and Bis-EUG on human leukemia K562 cells, exploring their ability to modulate apoptosis and cell proliferation.
Objective: To assess the in vitro anticancer effects of EUG and Bis-EUG on K562 cell lines through various assays measuring cell viability, apoptosis, gene expression, and nitric oxide release, with a focus on elucidating the mechanisms underlying their anticancer activity.
Methods: The study employed an inter-collaborative approach, utilizing MTT assays to determine the IC50 values of EUG and Bis-EUG on K562 cells. Gene expression analysis of pro-apoptotic genes Caspase-3 and Caspase-9 was performed using RT-qPCR. Apoptotic changes were further analyzed through flow cytometry and Hoechst 33258 staining to observe morphological alterations in treated cells. The release of nitric oxide (NO) as an indicator of anti-proliferative activity was measured using a Griess assay. Statistical analysis was conducted using GraphPad Prism Software, Version 9, and Microsoft Excel, with a significance threshold of p ≤ 0.05.
Results: The IC50 values for EUG and Bis-EUG were determined to be 16.7 µM and 0.14 mM, respectively. Gene expression profiling revealed a significant increase in Caspase-3 and Caspase-9 expression, indicating the activation of apoptotic pathways. Flow cytometry and Hoechst 33258 staining confirmed the induction of apoptosis, with noticeable changes in cell morphology and nuclear fragmentation. The NO release assay demonstrated a dose-dependent increase in NO levels, highlighting the compounds' anti-proliferative effects.
Conclusion: EUG and Bis-EUG exhibit potent anticancer effects on leukemia K562 cells by inducing apoptosis and inhibiting cell proliferation. The significant increase in NO levels and the activation of caspases suggest that these compounds may serve as effective chemotherapeutic agents. Further in vivo studies are warranted to explore their potential in cancer treatment regimens.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Du M, Chen W, Liu K, Wang L, Hu Y, Mao Y, Sun X, Luo Y, Shi J, Shao K, Huang H, Ye D. The Global Burden of Leukemia and Its Attributable Factors in 204 Countries and Territories: Findings from the Global Burden of Disease 2019 Study and Projections to 2030. J Oncol. 2022 Apr 25;2022:1612702
Yoo, C.B.; Han, K.T.; Cho, K.S.; Ha, J.; Park, H.J.; Nam, J.H.; Kil, U.H.; Lee, K.T. Eugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cells. Cancer Lett. 2005, 225, 41–52.
Zari AT, Zari TA, Hakeem KR. Anticancer Properties of Eugenol: A Review. Molecules. 2021 Dec 6;26(23):7407.
Hwang, S.M.; Lee, K.; Im, S.T.; Go, E.J.; Kim, Y.H.; Park, C.K. Co-Application of Eugenol and QX-314 Elicits the Prolonged Blockade of Voltage-Gated Sodium Channels in Nociceptive Trigeminal Ganglion Neurons. Biomolecules 2020, 10, 1513.
Kamatou GP, Vermaak I, Viljoen AM. Eugenol--from the remote Maluku Islands to the international market place: a review of a remarkable and versatile molecule. Molecules. 2012 Jun 6;17(6):6953-81.
Islam, S.S.; Al-Sharif, I.; Sultan, A.; Al-Mazrou, A.; Remmal, A.; Aboussekhra, A. Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway. Mol. Carcinog. 2018, 57, 333–346.
Carvalho AA, Andrade LN, de Sousa ÉB, de Sousa DP. Antitumor phenylpropanoids found in essential oils. Biomed Res Int. 2015;2015:392674.
Chung, K. S., Yoo, C. B., Lee, J. H., Lee, H. H., Park, S. E., Han, H. S., Lee, S. Y., Kwon, B. M., Choi, J. H., & Lee, K. T. (2021). Regulation of ROS-Dependent JNK Pathway by 2'-Hydroxycinnamaldehyde Inducing Apoptosis in Human Promyelocytic HL-60 Leukemia Cells. Pharmaceutics, 13(11), 1794.
Cheng Y, Li S, Gao L, Zhi K, Ren W. The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma. Front Oncol. 2021 Oct 22;11:761379.
Kilic U, Sahin K, Tuzcu M, Basak N, Orhan C, Elibol-Can B, Kilic E, Sahin F, Kucuk O. Enhancement of Cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallate. Front Nutr. 2015 Jan 26;1:28.
Padhy I, Paul P, Sharma T, Banerjee S, Mondal A. Molecular Mechanisms of Action of Eugenol in Cancer: Recent Trends and Advancement. Life (Basel). 2022 Nov 6;12(11):1795.
Wei W, Rosenkrans ZT, Luo QY, Lan X, Cai W. Exploiting Nanomaterial-mediated Autophagy for Cancer Therapy. Small Methods. 2019 Feb 13;3(2):1800365.
Chen, J. L., Wu, X., Yin, D., Jia, X. H., Chen, X., Gu, Z. Y., & Zhu, X. M. (2023). Autophagy inhibitors for cancer therapy: Small molecules and nanomedicines. Pharmacology & therapeutics, 249, 108485.
Padhy I, Paul P, Sharma T, Banerjee S, Mondal A. Molecular Mechanisms of Action of Eugenol in Cancer: Recent Trends and Advancement. Life (Basel). 2022 Nov 6;12(11):1795.
Begum, S. N., Ray, A. S., & Rahaman, C. H. (2022). A comprehensive and systematic review on potential anticancer activities of eugenol: From pre-clinical evidence to molecular mechanisms of action. Phytomedicine : international journal of phytotherapy and phytopharmacology, 107, 154456.
Cragg GM, Pezzuto JM. Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents. Med Princ Pract. 2016;25 Suppl 2(Suppl 2):41-59.
Kunnumakkara, A.B., Sailo, B.L., Banik, K. et al. Chronic diseases, inflammation, and spices: how are they linked?. J Transl Med 16, 14 (2018)
Sztiller-Sikorska M, Jakubowska J, Wozniak M, Stasiak M, Czyz M. A non-apoptotic function of caspase-3 in pharmacologically-induced differentiation of K562 cells. Br J Pharmacol. 2009 Aug;157(8):1451-62.
Jafri A, Siddiqui S, Rais J, Ahmad MS, Kumar S, Jafar T, Afzal M, Arshad M. Induction of apoptosis by piperine in human cervical adenocarcinoma via ROS mediated mitochondrial pathway and caspase-3 activation. EXCLI J. 2019 Mar 13;18:154-164.
Fangjun, L., & Zhijia, Y. (2018). Tumor suppressive roles of eugenol in human lung cancer cells. Thoracic cancer, 9(1), 25–29.
Kis B, Pavel IZ, Avram S, Moaca EA, Herrero San Juan M, Schwiebs A, Radeke HH, Muntean D, Diaconeasa Z, Minda D, Oprean C, Bojin F, Dehelean CA, Soica C, Danciu C. Antimicrobial activity, in vitro anticancer effect (MCF-7 breast cancer cell line), antiangiogenic and immunomodulatory potentials of Populus nigra L. buds extract. BMC Complement Med Ther. 2022 Mar 16;22(1):74.
Aru B, Güzelmeric E, Akgül A, Demirel GY, Kırmızıbekmez H. Antiproliferative Activity of Chemically Characterized Propolis from Turkey and Its Mechanisms of Action. Chemistry & Biodiversity. 2019 Jul;16(7):e1900189.
Al-Rawashde FA, Johan MF, Taib WRW, Ismail I, Johari SATT, Almajali B, Al-Wajeeh AS, Nazari Vishkaei M, Al-Jamal HAN. Thymoquinone Inhibits Growth of Acute Myeloid Leukemia Cells through Reversal SHP-1 and SOCS-3 Hypermethylation: In Vitro and In Silico Evaluation. Pharmaceuticals (Basel). 2021 Dec 9;14(12):1287.
Shehabeldine AM, Doghish AS, El-Dakroury WA, Hassanin MMH, Al-Askar AA, AbdElgawad H, Hashem AH. Antimicrobial, Antibiofilm, and Anticancer Activities of Syzygium aromaticum Essential Oil Nanoemulsion. Molecules. 2023 Aug 1;28(15):5812.
Hu BH, Zheng GL. Membrane disruption: an early event of hair cell apoptosis induced by exposure to intense noise. Brain Res. 2008 Nov 6;1239:107-18.
Wadia JS, Chalmers-Redman RM, Ju WJ, Carlile GW, Phillips JL, Fraser AD, Tatton WG. Mitochondrial membrane potential and nuclear changes in apoptosis caused by serum and nerve growth factor withdrawal: time course and modification by (-)-deprenyl. J Neurosci. 1998 Feb 1;18(3):932-47.
Islam, S. S., Al-Sharif, I., Sultan, A., Al-Mazrou, A., Remmal, A., & Aboussekhra, A. (2018). Eugenol potentiates cisplatin anti-cancer activity through inhibition of ALDH-positive breast cancer stem cells and the NF-κB signaling pathway. Molecular carcinogenesis, 57(3), 333–346.
Maqbool M, Bekele F, Fekadu G. Treatment Strategies Against Triple-Negative Breast Cancer: An Updated Review. Breast Cancer (Dove Med Press). 2022 Jan 11;14:15-24.
Hussain, A., Brahmbhatt, K., Priyani, A., Ahmed, M., Rizvi, T. A., & Sharma, C. (2011). Eugenol enhances the chemotherapeutic potential of gemcitabine and induces anticarcinogenic and anti-inflammatory activity in human cervical cancer cells. Cancer biotherapy & radiopharmaceuticals, 26(5), 519–527.